(Q45983549)

18 December 2017

title

Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. (English)

1 reference

18 December 2017

0 references

7

1 reference

18 December 2017

author name string

I B Skottheim

1

1 reference

18 December 2017

K Stormark

2

1 reference

18 December 2017

H Christensen

3

1 reference

18 December 2017

G S Jakobsen

4

1 reference

18 December 2017

J Hjelmesaeth

5

1 reference

18 December 2017

T Jenssen

6

1 reference

18 December 2017

R Sandbu

8

1 reference

18 December 2017

A Asberg

9

1 reference

18 December 2017

language of work or name

English

0 references

publication date

3 June 2009

1 reference

18 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

18 December 2017

volume

86

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

311-318

1 reference

18 December 2017

Trends in bariatric surgical procedures.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Evolution of operative procedures for the management of morbid obesity 1950-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

First-pass metabolism of midazolam by the human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Cytochrome P450 3A: ontogeny and drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Transporters and their impact on drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Therapeutic implications of the MDR-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Variable expression of CYP and Pgp genes in the human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Pharmacokinetics of the CYP 3A substrate simvastatin following administration of delayed versus immediate release oral dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

7 January 2021

Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

7 January 2021

The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

7 January 2021

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.82

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.82

1 reference

18 December 2017

1 reference

18 December 2017